Tebhajana Jatterjee
Analyst
Jones
Equibles does not estimate personal net worth.
About Tebhajana Jatterjee
Tebhajana Jatterjee is recorded as Analyst at Jones. Tebhajana Jatterjee has spoken on 1 earnings call across 1 company, most recently for Trevi Therapeutics, Inc. on November 9, 2026. The companies whose calls Tebhajana Jatterjee spoke on are classified in the Healthcare sector.
Tebhajana Jatterjee on recent calls
“Okay, and I'm curious how low would the RCC approvable dose need to be to allow you to launch that as a separate brand from the ITF program and to preserve differential pricing?”
Affiliation history
-
Jones
Analyst
Transcript header (unverified)
Current